CHAMPIONS ONCOLOGY, INC.: accounts_receivable
| Value | {"amount": 11539000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2025-10-31) |
| Status | current |
| Entity | CHAMPIONS ONCOLOGY, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T07:55:53.064480+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c61305ca-026b-4525-bc1a-6f3f7340afb2
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-25-057082 · Open the official SEC filing →Retrieved: 2026-08-19T07:55:53.064480+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000771856/accounts-receivable/2025-10-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c61305ca-026b-4525-bc1a-6f3f7340afb2
History
- no predecessors — first report